1. Home
  2. ALGS vs HYPR Comparison

ALGS vs HYPR Comparison

Compare ALGS & HYPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALGS
  • HYPR
  • Stock Information
  • Founded
  • ALGS 2018
  • HYPR 2014
  • Country
  • ALGS United States
  • HYPR United States
  • Employees
  • ALGS N/A
  • HYPR N/A
  • Industry
  • ALGS Biotechnology: Pharmaceutical Preparations
  • HYPR Medical Specialities
  • Sector
  • ALGS Health Care
  • HYPR Health Care
  • Exchange
  • ALGS Nasdaq
  • HYPR Nasdaq
  • Market Cap
  • ALGS 53.0M
  • HYPR 55.9M
  • IPO Year
  • ALGS 2020
  • HYPR N/A
  • Fundamental
  • Price
  • ALGS $9.99
  • HYPR $1.39
  • Analyst Decision
  • ALGS Strong Buy
  • HYPR Strong Buy
  • Analyst Count
  • ALGS 2
  • HYPR 3
  • Target Price
  • ALGS $60.00
  • HYPR $1.28
  • AVG Volume (30 Days)
  • ALGS 71.7K
  • HYPR 276.6K
  • Earning Date
  • ALGS 11-05-2025
  • HYPR 11-11-2025
  • Dividend Yield
  • ALGS N/A
  • HYPR N/A
  • EPS Growth
  • ALGS N/A
  • HYPR N/A
  • EPS
  • ALGS N/A
  • HYPR N/A
  • Revenue
  • ALGS $3,174,000.00
  • HYPR $10,797,000.00
  • Revenue This Year
  • ALGS N/A
  • HYPR $12.92
  • Revenue Next Year
  • ALGS $28.79
  • HYPR $32.10
  • P/E Ratio
  • ALGS N/A
  • HYPR N/A
  • Revenue Growth
  • ALGS N/A
  • HYPR N/A
  • 52 Week Low
  • ALGS $3.76
  • HYPR $0.53
  • 52 Week High
  • ALGS $46.80
  • HYPR $1.90
  • Technical
  • Relative Strength Index (RSI)
  • ALGS 51.70
  • HYPR 62.27
  • Support Level
  • ALGS $8.90
  • HYPR $1.36
  • Resistance Level
  • ALGS $11.65
  • HYPR $1.50
  • Average True Range (ATR)
  • ALGS 0.76
  • HYPR 0.08
  • MACD
  • ALGS -0.25
  • HYPR 0.01
  • Stochastic Oscillator
  • ALGS 39.64
  • HYPR 75.00

About ALGS Aligos Therapeutics Inc.

Aligos Therapeutics Inc is a clinical stage biopharmaceutical company. It is engaged in developing novel therapeutics to address unmet medical needs in viral and liver diseases, including chronic hepatitis B and coronaviruses, and therapeutics for nonalcoholic steatohepatitis (NASH). The company's pipeline includes ALG-010133, ALG-000184, ALG-020572 and ALG-055009, among others.

About HYPR Hyperfine Inc.

Hyperfine Inc is a medical device company that created Swoop. The Swoop Portable MR Imaging System produces high-quality images at a lower magnetic field strength than conventional MRI scanners. The company derives its revenue from sale of sales of MRI devices and service sales which consist of sales from subscriptions of bundled devices, maintenance, and software.

Share on Social Networks: